ArticleMolecular therapy oncolytics2022

Efficacy of a third-generation oncolytic herpes simplex virus in refractory soft tissue sarcoma xenograft models.

Masahiko Hatta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.